CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
REBORNE focuses on developing synthetic bone grafts combined with stem cells to improve bone healing in orthopedic and maxillofacial surgeries. The project includes clinical trials across Europe to assess the safety and effectiveness of these advanced biomaterials.
Bone is among the most frequently transplanted tissue with about 1 million procedures annually in Europe.
The worldwide market of bone replacement materials is currently estimated at 5 billion € with a 10% annual growth.
Despite their considerable disadvantages, including the risk of disease transfer and immunologic rejection, limited supply of bone, costs and complications, allografts and autografts account for more than 80% of total graft volume.
Significant growth opportunities exist for synt…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, La Plaine Saint Denis
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
France, Vigneux De Bretagne
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO
Italy, Milano
Type: Other
Activity type: Other
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
